Europe Virology Market Size & Outlook, 2025-2033

Europe Virology Market Insights

As highlighted in Reed Intelligence analysis, the Europe Virology Market, valued at USD 797.72 Million in 2024, is estimated to achieve USD 1259.66 Million by 2033.
The market is estimated to grow at a CAGR of 5.13% spanning 2026 to 2033.
By market size, Diagnosing Test led the By Type category in 2024.
The By Type segment led by Viral Infection is estimated to post the fastest growth, sustaining its position as the most lucrative during the forecast timeframe.

Other Key Findings

Europe held 27.99% share of the global Virology Market size in 2024.
United States is expected to remain the largest contributor to the global market size by 2033.
By 2033, Nordic is anticipated to record the highest growth in Europe, with the market size expected to reach USD 64.42 Million.

Report Summary

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 797.72 Million
Market Size In 2033	USD 1259.66 Million
Largest segment	Diagnosing Test
Units	Revenue in USD Million
CAGR	5.13% (2025-2033)
Segmnetation Covered
Europe	Germany United Kingdom France Italy Spain Russia Nordic Benelux
By Type	Diagnosing Test Viral Infection Controlling Methods Antiviral Therapeutics Interferon
By Applications	Skin and Soft Tissue Infections Respiratory Tract Infections GI Tract Infections Urinary Tract Infections Eye Infections CNS Infections Others
By End-Users	Hospitals Clinics Diagnostic Centers Blood Banks Others
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Europe Virology Market Country 2025-2033 (USD Million)

Europe	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Germany	XX.x	XX.x	XX.x	199.43	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
United Kingdom	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
France	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Italy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Spain	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Russia	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Nordic	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Benelux	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Europe Virology Market By Type 2025-2033 (USD Million)

By Type	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Diagnosing Test	XX.x	XX.x	XX.x	350.44	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Viral Infection	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Controlling Methods	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Antiviral Therapeutics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Interferon	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Europe Virology Market By Applications 2025-2033 (USD Million)

By Applications	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Skin and Soft Tissue Infections	XX.x	XX.x	XX.x	274.34	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Respiratory Tract Infections	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
GI Tract Infections	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Urinary Tract Infections	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Eye Infections	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
CNS Infections	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Europe Virology Market By End-Users 2025-2033 (USD Million)

By End-Users	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Hospitals	XX.x	XX.x	XX.x	287.1	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Clinics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Diagnostic Centers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Blood Banks	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.